Stock profile

Hikma Pharmaceuticals PLC

HIK.LSE LSE GBX ISIN GB00B0LCW083

Market tone: Positive sentiment score 1.00 from 1 mentions, latest 20 Mar 2026.

Open 1,452.00p Prev close 1,460.00p Volume 421,241
Frequency Semi-annual 1.8 events/year
Trend Falling 2022-2026 payout trend
Volatility 21.91% annual payout CV
Growth -4.26% annualised payout

Recent Dividends

Trade analysis
Dividend37.2pFinal Event yield1.71% - 1.85%declared to ex-div Ex-div drop-2.79%price move Decl26 Feb Ex-div20 Mar Pay01 May
Dividend27.0pInterim Event yield1.49% - 1.55%declared to ex-div Ex-div drop-1.21%price move Decl07 Aug Ex-div14 Aug Pay18 Sep
Dividend35.3pFinal Event yield2.57% - 2.96%declared to ex-div Ex-div drop-3.11%price move Decl26 Feb Ex-div19 Mar Pay30 Apr
Price History 18 Nov 2024 to 05 Jun 2026
History dividend: 20 Mar 2025 | Declared: 26 Feb 2025 | Dividend: 37.2p | Yield before ex: 1.79% | Ex-drop: -2.79% | Window yield range: 1.71% to 1.85% History dividend: 14 Aug 2025 | Declared: 07 Aug 2025 | Dividend: 27.0p | Yield before ex: 1.49% | Ex-drop: -1.21% | Window yield range: 1.49% to 1.55% History dividend: 19 Mar 2026 | Declared: 26 Feb 2026 | Dividend: 35.3p | Yield before ex: 2.75% | Ex-drop: -3.11% | Window yield range: 2.57% to 2.96% 1,099.08 1,432.29 1,765.50 2,098.71 2,431.92 Jan 25 Apr 25 Jul 25 Oct 25 Jan 26 Apr 26

News

EODHD feed
04 Jun 2026 Positive 1.00 Hikma comments on Supreme Court of the United States' unanimous decision in favour of Hikma LONDON, June 4, 2026 /PRNewswire/ -- Hikma Pharmaceuticals PLC, along with its wholly owned subsidiary Hikma Pharmaceuticals USA Inc., (Hikma) offered the following comments on tod Fda Approval Generic Medicines Patent Litigation Pharmaceuticals 01 Jun 2026 Positive 1.00 Hikma Pharmaceuticals Announces Major Expansion in Ohio, Creating 350 New Jobs and Investing $267 Million Cleveland and Columbus, Ohio, June 01, 2026 (GLOBE NEWSWIRE) -- COLUMBUS and CLEVELAND, Ohio – Ohio Governor Mike DeWine, along with Hikma Pharmaceuticals, JobsOhio, the City of Company Announcement Government News Jobs Manufacturing 01 Jun 2026 Positive 1.00 Hikma Pharmaceuticals Announces Major Expansion in Ohio, Creating 350 New Jobs and Investing $267 Million Cleveland and Columbus, Ohio, June 01, 2026 (GLOBE NEWSWIRE) -- COLUMBUS and CLEVELAND, Ohio – Ohio Governor Mike DeWine, along with Hikma Pharmaceuticals, JobsOhio, the City of Be Job Creation Manufacturing Ohio Pharmaceuticals 19 May 2026 Positive 1.00 How The Hikma Pharmaceuticals (LSE:HIK) Narrative Is Shifting After Analyst Valuation Resets Never miss an important update on your stock portfolio and cut through the noise. Over 7 million investors trust Simply Wall St to stay informed where it matters for FREE. Hikma P Guidance Price Target Price Target Ratings 30 Apr 2026 Positive 0.99 Pfizer (PFE) Reaches Settlement to Extend VYNDAMAX Patent Protection Until 2031 Pfizer Inc. (NYSE:PFE) is one of the most active US stocks to buy right now. On April 28, Pfizer entered into settlement agreements with generic drug manufacturers Dexcel Pharma, H Cardiovascular Litigation Patent Protection Pharmaceuticals 28 Apr 2026 Positive 0.99 Pfizer Reaches Three Settlement Agreements for VYNDAMAX NEW YORK, April 28, 2026--(BUSINESS WIRE)--Pfizer Inc. (NYSE: PFE) today announced that it has entered into settlement agreements with generic drug manufacturers Dexcel Pharma, Hik Cardiomyopathy Market Leadership Patent Litigation Pharma

Historical Dividends

Total dividends and yield-at-ex-date by year
Payout trend 14.23% Growing · 2021-2025 payout CAGR
Payout volatility 20.45% Variable · std dev / average payout
Peak payout67.9p
Peak annual yield4.86%
2021
1.58%
37.7p
18 Mar 24.7p 19 Aug 13.0p
2022
2.40%
42.0p
17 Mar 26.0p 18 Aug 16.0p
2023
2.55%
49.4p
23 Mar 29.5p 10 Aug 19.9p
2024
3.11%
61.4p
21 Mar 37.1p 15 Aug 24.3p
2025
3.37%
64.2p
20 Mar 37.2p 14 Aug 27.0p
2026 This year
4.86%
66.0p
19 Mar 35.3p 14 Aug 30.7p
2027 Projection
4.61%
67.9p
19 Mar 37.2p 14 Aug 30.7p
YearEx-dateDeclaredRecordPaymentPeriodValue
2026 19 Mar 2026 26 Feb 2026 - 30 Apr 2026 Final 0.3529 GBP
2025 14 Aug 2025 07 Aug 2025 - 18 Sep 2025 Interim 0.2699 GBP
2025 20 Mar 2025 26 Feb 2025 - 01 May 2025 Final 0.3721 GBP
2024 15 Aug 2024 08 Aug 2024 15 Aug 2024 20 Sep 2024 Interim 0.2426 GBP
2024 21 Mar 2024 22 Feb 2024 21 Mar 2024 03 May 2024 Final 0.3714 GBP
2023 10 Aug 2023 03 Aug 2023 10 Aug 2023 15 Sep 2023 Interim 0.1988 GBP
2023 23 Mar 2023 23 Feb 2023 23 Mar 2023 05 May 2023 Final 0.2952 GBP
2022 18 Aug 2022 04 Aug 2022 18 Aug 2022 20 Sep 2022 Interim 0.1600 GBP
2022 17 Mar 2022 24 Feb 2022 17 Mar 2022 28 Apr 2022 Final 0.2600 GBP
2021 19 Aug 2021 06 Aug 2021 19 Aug 2021 20 Sep 2021 Interim 0.1300 GBP
2021 18 Mar 2021 25 Feb 2021 18 Mar 2021 26 Apr 2021 Final 0.2470 GBP
2020 20 Aug 2020 07 Aug 2020 20 Aug 2020 21 Sep 2020 Interim 0.1200 GBP
2020 19 Mar 2020 27 Feb 2020 19 Mar 2020 07 May 2020 Final 0.2422 GBP
2019 22 Aug 2019 09 Aug 2019 22 Aug 2019 23 Sep 2019 Interim 0.1400 GBP

Upcoming Dividends

Declared and projected dividend cycle
Ex-dateStatusPeriodDividendEst. yield
14 Aug 2026 Predicted Interim 0.3066 GBP 2.08%
19 Mar 2027 Predicted Final 0.3721 GBP 2.53%

Recovery Speed

Recovered by trading week
1w
1 <= 5d trading days
2w
2 <= 10d trading days
3w
2 <= 15d trading days
4w
2 <= 20d trading days
5w
2 <= 25d trading days
6w
3 <= 30d trading days

Recovery Signature

Post ex-div behaviour
Median recovery9dtrading days to regain pre-ex close
Recovered50.00%events recovered inside 6w
Drop capture105.69%ex-drop as share of dividend paid
Score49speed, consistency, and drift blend
+15% +5% 0% -5% -15% Ex 1w 2w 3w 4w 5w 6w
Bold white line = average visible recovery curve 6 events selected